119.10
Overview
News
Price History
Option Chain
Financials
Why MS Down?
Discussions
Forecast
Stock Split
Dividend History
Morgan Stanley stock is traded at $119.10, with a volume of 4.68M.
It is up +0.65% in the last 24 hours and up +18.01% over the past month.
See More
Previous Close:
$118.33
Open:
$118.33
24h Volume:
4.68M
Relative Volume:
0.63
Market Cap:
$185.17B
Revenue:
$59.92B
Net Income/Loss:
$14.29B
P/E Ratio:
13.98
EPS:
8.52
Net Cash Flow:
$-30.33B
1W Performance:
+3.19%
1M Performance:
+18.01%
6M Performance:
-7.27%
1Y Performance:
+24.33%
Morgan Stanley Stock (MS) Company Profile
Name
Morgan Stanley
Sector
Industry
Phone
212-761-4000
Address
1585 BROADWAY, NEW YORK, NY
Compare MS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
MS
Morgan Stanley
|
119.10 | 185.17B | 59.92B | 14.29B | -30.33B | 8.52 |
![]()
GS
Goldman Sachs Group Inc
|
551.92 | 168.01B | 54.36B | 14.88B | -24.50B | 43.09 |
![]()
SCHW
Charles Schwab Corp
|
84.01 | 147.82B | 20.47B | 6.49B | 2.05B | 3.30 |
![]()
HOOD
Robinhood Markets Inc
|
49.99 | 43.34B | 3.26B | 1.59B | 1.06B | 1.76 |
![]()
TW
Tradeweb Markets Inc
|
143.74 | 29.51B | 1.83B | 523.75M | 833.62M | 2.43 |
Morgan Stanley Stock (MS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-26-24 | Downgrade | HSBC Securities | Buy → Hold |
Nov-15-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
Oct-04-24 | Upgrade | HSBC Securities | Hold → Buy |
Sep-11-24 | Downgrade | Goldman | Buy → Neutral |
Aug-02-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
Jul-17-24 | Downgrade | Oppenheimer | Outperform → Perform |
Jan-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
Jan-17-24 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
Jan-09-24 | Downgrade | HSBC Securities | Buy → Hold |
Nov-28-23 | Downgrade | Societe Generale | Buy → Hold |
Nov-20-23 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
Oct-23-23 | Downgrade | Odeon | Buy → Hold |
Oct-20-23 | Upgrade | Wolfe Research | Underperform → Peer Perform |
Oct-11-23 | Downgrade | UBS | Buy → Neutral |
Sep-07-23 | Initiated | HSBC Securities | Buy |
Jul-12-23 | Upgrade | Odeon | Hold → Buy |
Jan-18-23 | Downgrade | Citigroup | Buy → Neutral |
Jan-10-23 | Upgrade | Odeon | Sell → Hold |
Jan-04-23 | Downgrade | Wolfe Research | Outperform → Underperform |
Oct-05-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
Sep-06-22 | Downgrade | Odeon | Hold → Sell |
May-03-22 | Upgrade | Oppenheimer | Perform → Outperform |
Jan-28-22 | Downgrade | Odeon | Buy → Hold |
Dec-03-21 | Upgrade | Citigroup | Neutral → Buy |
Oct-15-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
Oct-04-21 | Reiterated | Jefferies | Buy |
Sep-29-21 | Downgrade | Oppenheimer | Outperform → Perform |
Sep-28-21 | Downgrade | Berenberg | Buy → Hold |
Aug-13-21 | Downgrade | Seaport Global Securities | Buy → Neutral |
Jul-07-21 | Resumed | Keefe Bruyette | Outperform |
Jun-09-21 | Initiated | Jefferies | Buy |
Apr-21-21 | Upgrade | Berenberg | Hold → Buy |
Mar-02-21 | Upgrade | Daiwa Securities | Neutral → Outperform |
Jan-06-21 | Initiated | Daiwa Securities | Neutral |
Jan-04-21 | Upgrade | Barclays | Equal Weight → Overweight |
Nov-10-20 | Downgrade | Citigroup | Buy → Neutral |
Oct-13-20 | Resumed | JP Morgan | Overweight |
Jul-08-20 | Initiated | Seaport Global Securities | Buy |
Jun-24-20 | Upgrade | DA Davidson | Neutral → Buy |
Jun-23-20 | Reiterated | UBS | Buy |
May-21-20 | Upgrade | Odeon | Hold → Buy |
Apr-14-20 | Upgrade | Societe Generale | Sell → Buy |
Mar-13-20 | Upgrade | Goldman | Neutral → Buy |
Mar-04-20 | Upgrade | Citigroup | Neutral → Buy |
Feb-21-20 | Downgrade | DA Davidson | Buy → Neutral |
Feb-20-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Jan-21-20 | Downgrade | Citigroup | Buy → Neutral |
Jan-17-20 | Downgrade | Piper Sandler | Overweight → Neutral |
Jan-13-20 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
Jan-09-20 | Initiated | DA Davidson | Buy |
Jan-06-20 | Downgrade | Deutsche Bank | Buy → Hold |
Oct-29-19 | Downgrade | Odeon | Buy → Hold |
Oct-10-19 | Upgrade | Sandler O'Neill | Hold → Buy |
Jul-12-19 | Upgrade | Citigroup | Neutral → Buy |
Apr-18-19 | Downgrade | Citigroup | Buy → Neutral |
View All
Morgan Stanley Stock (MS) Latest News
Morgan Stanley Launches Power E*Trade Pro, a New Platform for the Most Active Traders - Funds Society
Bitcoin Hits Critical Mass—Morgan Stanley Flags It As Reserve-Grade - Bitcoinist.com
Morgan Stanley clears SEC 'sweeps' probe, still faces state scrutiny - financial-planning.com
Schwab and Morgan Stanley join the crypto race. They are way late, say analysts - dlnews.com
Morgan Stanley Says SEC Closed Cash-Sweep Investigation - Barron's
RXO Faces Price Target Cut by Morgan Stanley After Q1 Miss | RXO Stock News - GuruFocus
Macau gaming sector might have reached a new ceilingMorgan Stanley Managing Director - Macau Business
Morgan Stanley Adjusts Price Target on Verisk Analytics to $317 From $305, Maintains Equalweight Rating - marketscreener.com
SEC closes inquiry into Morgan Stanley’s cash sweep program - Citywire
Stora Enso (SEOAY) Price Target Reduced by Morgan Stanley Analyst | SEOAY Stock News - GuruFocus
Morgan Stanley holds Marvell stock rating, price target at $90 By Investing.com - Investing.com India
Delivery Hero (DLVHF) Target Price Adjusted by Morgan Stanley | DLVHF Stock News - GuruFocus
CRH (CRH) Price Target Reduced by Morgan Stanley Analyst | CRH Stock News - GuruFocus
Form FWP Morgan Stanley Finance Filed by: Morgan Stanley Finance LLC - StreetInsider
Morgan Stanley Adjusts Price Target for Schindler (SHLAF) | SHLAF Stock News - GuruFocus
Form 424B2 MORGAN STANLEY - StreetInsider
Morgan Stanley holds Marvell stock rating, price target at $90 - Investing.com
SCR Partners Appoints Lisa Kampf as Senior Vice President as the Company Broadens Financial and Strategic Communications Offering - GlobeNewswire Inc.
Morgan Stanley to see no SEC penalty on cash sweeps - Banking Dive
- Yahoo Finance
Form FWP MORGAN STANLEY Filed by: MORGAN STANLEY - StreetInsider
SEC Form FWP filed by Morgan Stanley - Quantisnow
Morgan Stanley Has Lowered Expectations for Wendy's (NASDAQ:WEN) Stock Price - MarketBeat
Morgan Stanley Beats SEC Cash Sweep Review But Still Faces State Inquiry - AdvisorHub
Morgan Stanley Lowers Price Target on Micron Technology to $98 From $112, Maintains Equalweight Rating - marketscreener.com
Walmart Fiscal Q1 to See 'Modest Upside' Despite Tariffs, Morgan Stanley Says - marketscreener.com
Morgan Stanley Issues Pessimistic Forecast for Huntsman (NYSE:HUN) Stock Price - MarketBeat
Lowe's Companies (NYSE:LOW) Price Target Lowered to $255.00 at Morgan Stanley - MarketBeat
Madison Square Garden Sports (NYSE:MSGS) Given New $215.00 Price Target at Morgan Stanley - MarketBeat
Morgan Stanley Adjusts Price Target on Gartner to $490 From $500, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Cuts Church & Dwight (NYSE:CHD) Price Target to $100.00 - MarketBeat
Jazz Pharmaceuticals (JAZZ): Morgan Stanley Adjusts Price Target | JAZZ Stock News - GuruFocus
Aramark (ARMK) Stock Target Price Raised by Morgan Stanley | ARMK Stock News - GuruFocus
Upstart Holdings (UPST) Target Price Lowered by Morgan Stanley | UPST Stock News - GuruFocus
Sarepta Therapeutics (SRPT) Price Target Lowered by Morgan Stanley | SRPT Stock News - GuruFocus
EA Stock: Morgan Stanley Raises Price Target for Electronic Arts | EA Stock News - GuruFocus
Morgan Stanley Downgrades Skechers (SKX) and Lowers Price Target | SKX Stock News - GuruFocus
U.S. dollar weakening will be long-term move: Morgan Stanley Investment Management - CNBC
The Zacks Analyst Blog Highlights The Goldman Sachs, JPMorgan and Morgan Stanley - Yahoo Finance
Wizz Air appoints Morgan Stanley as joint corporate broker By Investing.com - Investing.com India
Morgan Stanley Cuts Price Target on Cricut to $2.90 From $3.10, Keeps Underweight Rating - marketscreener.com
Morgan Stanley Raises Price Target on Halozyme Therapeutics to $73 From $67, Keeps Overweight Rating - marketscreener.com
Morgan Stanley Cuts Price Target on Jazz Pharmaceuticals to $166 From $183, Keeps Overweight Rating - marketscreener.com
Morgan Stanley Raises Price Target on SolarEdge Technologies to $11 From $10, Keeps Underweight Rating - marketscreener.com
Micron price target lowered to $98 from $112 at Morgan Stanley - TipRanks
Wizz Air appoints Morgan Stanley as joint corporate broker - Investing.com
Morgan Stanley Cuts Price Target on Revolve Group to $19 From $21, Keeps Equalweight Rating - marketscreener.com
Morgan Stanley Raises Price Target on Klaviyo to $40 From $34, Keeps Equalweight Rating - marketscreener.com
Morgan Stanley Lifts Price Target on Grocery Outlet Holding to $13 From $10, Keeps Underweight Rating - marketscreener.com
Morgan Stanley Stock: Analyst Estimates & Ratings - Nasdaq
Morgan Stanley maintains IBM stock rating and $233 target - Investing.com
Morgan Stanley Stock (MS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):